Abstract: Methods of causing an improvement in central nervous system function are provided. The methods include administering an aliquot of stem cells to the patient, the cells being derived from blood, e.g., umbilical cord blood. In some cases a growth factor is administered with the cells.
Type:
Grant
Filed:
November 19, 2012
Date of Patent:
July 7, 2015
Assignees:
The General Hospital Corporation, ViaCord LLC
Inventors:
Morey Kraus, Seth Finklestein, Paul T. Clark
Abstract: The invention features a method for treating or preventing ischemia in a mammal by administering unrestricted somatic stem cells (USSCs) to the mammal.
Abstract: The invention features a method for treating or preventing ischemia in a mammal by administering unrestricted somatic stem cells (USSCs) to the mammal.
Abstract: Methods of causing an improvement in central nervous system function are provided. The methods include administering an aliquot of stem cells to the patient, the cells being derived from blood, e.g., umbilical cord blood. In some cases a growth factor is administered with the cells.
Type:
Application
Filed:
November 19, 2012
Publication date:
June 6, 2013
Applicants:
The General Hospital Corporation, ViaCord, LLC
Inventors:
ViaCord, LLC, The General Hospital Corporation
Abstract: Methods of causing an improvement in central nervous system function are provided. The methods include administering an aliquot of stem cells to the patient, the cells being derived from blood, e.g., umbilical cord blood. In some cases a growth factor is administered with the cells.
Type:
Grant
Filed:
May 11, 2010
Date of Patent:
December 25, 2012
Assignees:
The General Hospital Corp., ViaCord, LLC
Inventors:
Morey Kraus, Seth Finklestein, Paul Clark